ArticleStem cell reports2025
Pen-2 regulates glial homeostasis by coordinating self-renewal and transdifferentiation programs in oligodendrocyte precursor cells.
Article in Stem cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Presenilin enhancer 2 (Pen-2) is implicated in neurological diseases characterized by glial dysregulation. To investigate whether oligodendrocytic γ-secretase activity is important for the maintenance of glial populations, we analyzed two conditional knockout (cKO) mouse models lacking Pen-2 or nicastrin. Both models exhibited similar expansions of oligodendrocyte precursor cells (OPCs) and astrocytes in the CNS. To test whether STAT3 mediates Pen-2-dependent glial homeostasis, we inactivated Stat3 in Pen-2 cKO mice. Intriguingly, STAT3 deficiency did not attenuate OPC expansion but normalized astrocyte numbers. We further demonstrated that Pen-2 represses Ascl1 expression via HES1 and that Ascl1 knockdown rescues the aberrant self-renewal capacity of Pen-2-deficient OPCs. Collectively, these results uncover a dual regulatory mechanism by which Pen-2 maintains glial homeostasis by (1) restraining OPC self-renewal through the HES1-ASCL1 axis and (2) suppressing OPC-to-astrocyte transdifferentiation in a STAT3-dependent manner. Our findings provide novel insights into glial abnormalities in PEN-2-linked neurological diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.